The Trio-Smart malabsorption breath test by Gemelli Biotech offers a comprehensive diagnostic approach for individuals experiencing gastrointestinal symptoms such as bloating, gas, abdominal pain, constipation, and diarrhea. By measuring hydrogen, methane, and hydrogen sulfide levels in the breath, this test can detect three variations of bacterial overgrowth: small intestinal bacterial overgrowth (SIBO), intestinal methanogenic overgrowth (IMO), and excess hydrogen sulfide. [8.,9.]
Through at-home sample collection and analysis at a CLIA-certified lab, patients and healthcare providers gain insight into the underlying causes of gastrointestinal symptoms, facilitating the development of tailored treatment plans. [8.]
Breath tests are effective in detecting conditions like small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption, which are strongly linked to GI symptoms. These tests offer a noninvasive and cost-effective approach to diagnosing GI disorders, providing valuable insights for effective management.
Many individuals with functional gut disorders may not realize the impact of their diet on their GI symptoms. Particularly, those experiencing chronic symptoms like abdominal pain, bloating, flatulence, and altered bowel movements may overlook the possibility of carbohydrate malabsorption or SIBO. Breath tests offer specific and sensitive diagnostic capabilities, allowing healthcare providers to confirm or rule out these conditions in such patients.
Elevated levels of hydrogen, methane, and hydrogen sulfide can indicate disruptions in the microbiome, leading to various gastrointestinal symptoms. Depending on the substrate used, a carbohydrate malabsorption may also be discovered.
The Trio-Smart test provides data to guide treatment decisions, offering patients a personalized approach to addressing their symptoms and improving their overall well-being.
Breath testing serves as a valuable tool in identifying various gut microbiome-related conditions by analyzing fermented gasses in exhaled breath samples. The three primary gasses measured in breath testing are hydrogen, methane, and hydrogen sulfide, which can provide insights into disorders affecting gut health. These gasses are produced by bacteria in the gastrointestinal tract during the fermentation of sugars, [7.]
High levels of hydrogen, methane, or hydrogen sulfide in breath testing can have distinct clinical implications. Elevated hydrogen levels are commonly associated with small intestinal bacterial overgrowth (SIBO), where excess bacteria in the small intestine produce hydrogen gas during the fermentation of carbohydrates. This can lead to symptoms such as bloating, abdominal discomfort, and diarrhea.
High methane levels are indicative of intestinal methanogenic overgrowth (IMO), which is often linked to constipation. Methane is produced by archaea in the gut that consume hydrogen, slowing gut transit time and potentially contributing to constipation.
In contrast, elevated hydrogen sulfide levels in breath testing are associated with excess hydrogen sulfide production in the gut microbiome. This condition, previously undetectable by traditional breath tests, is linked to symptoms such as diarrhea and abdominal pain. Excess hydrogen sulfide is believed to be produced by sulfate-reducing bacteria and can lead to gut inflammation and dysbiosis.
Each gas—hydrogen, methane, and hydrogen sulfide—provides valuable clinical information about the underlying gut microbiome composition and function, helping healthcare providers tailor treatment strategies for patients with gastrointestinal symptoms. Therefore, understanding the clinical relevance of high levels of these gasses in breath testing is crucial for accurate diagnosis and management of gut-related disorders.
Additionally, the substrate chosen may also provide clinical insight. While glucose hydrogen breath tests are preferred for diagnosing SIBO, lactose and fructose hydrogen breath tests are utilized to identify lactose and fructose malabsorption, respectively.
A positive finding on a Trio-Smart breath test using a fructose substrate indicates potential malabsorption of fructose in the small intestine, which can lead to gastrointestinal symptoms such as bloating, abdominal pain, diarrhea, and flatulence. Fructose malabsorption occurs when the small intestine is unable to properly absorb fructose due to deficiencies in fructose transporters or enzyme activity. As a result, unabsorbed fructose reaches the colon where it is fermented by gut bacteria, leading to the production of gasses such as hydrogen and methane, which can be detected in breath testing.
The clinical significance of a positive finding on a Trio-Smart breath test with a fructose substrate lies in its ability to identify individuals with fructose malabsorption, allowing for targeted dietary interventions and symptom management. By confirming fructose malabsorption as the underlying cause of gastrointestinal symptoms, healthcare providers can advise patients to limit their intake of fructose-containing foods and beverages, such as fruits, honey, and high-fructose corn syrup. Additionally, supplementation with digestive enzymes that aid in fructose digestion may be recommended to improve symptoms and overall quality of life.
Fructose, lactose, and sucrose are commonly used substrates in breath testing for bacterial overgrowth. The choice of substrate depends on the suspected underlying cause of the patient's symptoms and their dietary habits. [7.]
Fructose is often used to assess for fructose malabsorption, which can contribute to symptoms of bloating, gas, and diarrhea. Patients suspected of having fructose intolerance may undergo breath testing with fructose to evaluate their ability to absorb this sugar.
Lactose, found in dairy products, is commonly used to assess for lactose intolerance. Breath testing with lactose can help diagnose lactase deficiency, which leads to the inability to digest lactose and can result in symptoms such as bloating, abdominal pain, and diarrhea after consuming dairy products.
Sucrose, although less commonly used compared to fructose and lactose, can also be used as a substrate in breath testing for SIBO. Sucrose is a disaccharide composed of glucose and fructose, and its malabsorption may contribute to gastrointestinal symptoms in certain individuals. [4.]
Lactulose is an additional substrate used for breath testing. Lactulose hydrogen breath tests are commonly used to assess GI motility by measuring orocecal transit time. [7.]
Breath testing with sucrose can help identify patients with sucrase-isomaltase deficiency or other conditions affecting the digestion and absorption of sucrose. Overall, the selection of substrate for SIBO breath testing should be based on the patient's clinical presentation, dietary history, and suspected underlying disorders, with the goal of accurately diagnosing and managing their gastrointestinal symptoms.
Individuals with Unexplained Gastrointestinal Symptoms: Those experiencing chronic symptoms such as bloating, gas, abdominal pain, and altered bowel habits (diarrhea or constipation) could benefit from the trio-smart malabsorption breath test for fructose. Studies have shown that fructose malabsorption is common in individuals with functional gastrointestinal disorders (FGIDs) and can contribute to these symptoms. [2.]
Patients with Suspected Irritable Bowel Syndrome (IBS): IBS is a common condition characterized by abdominal discomfort or pain and altered bowel habits. Research suggests a significant association between fructose malabsorption and IBS symptoms. [kim, <<<<<< Therefore, individuals with suspected IBS who have not responded to conventional treatments may benefit from testing for fructose malabsorption.
Individuals with Suspected Fructose Intolerance: Fructose intolerance is a condition where the body has difficulty digesting and absorbing fructose, leading to gastrointestinal discomfort. The trio-smart malabsorption breath test for fructose can help diagnose fructose intolerance and guide dietary management. [3.]
Patients with Unexplained Abdominal Discomfort: Those experiencing unexplained abdominal discomfort or pain, especially after consuming foods high in fructose, may benefit from fructose breath testing. Research suggests that identifying and addressing fructose malabsorption can alleviate symptoms and improve quality of life [1., 3.]
Individuals Seeking Dietary Management: For individuals looking to optimize their diet and improve gastrointestinal symptoms, identifying fructose malabsorption through breath testing can guide dietary modifications. This personalized approach can help individuals avoid foods high in fructose and alleviate symptoms associated with malabsorption. [3., 5.]
If you are taking antibiotics, consult with your healthcare provider regarding the timing of sample collection. Some antibiotics should be avoided before sample collection.
Avoid the following medications for at least 7 days before sample collection:
You must follow a restricted diet the day before sample collection. YOU CAN ONLY EAT AND DRINK THE FOLLOWING ITEMS:
Food:
Seasonings:
Drinks
You must fast for 8-12 hours before sample collection. DO NOT eat or drink anything during this fasting period and sample collection time, except for your glucose or lactulose solution. You may drink a few sips of water if necessary.
Complete a sticker label with the following information:
Repeat steps 4-14 for the second sample collection.
Immediately after collecting your second sample, drink the sugar substrate solution within 5 minutes. Drink the entire substrate dose provided in your collection kit. Wait 30 minutes before collecting your next sample. Repeat steps 4-14 for each sample collection. Wait 30 minutes between each sample collection.
Once you have finished all eight collections, place all filled collection bags into the provided biohazard bag. Seal the bag tightly.
Complete the test requisition form. Click here for instructions on completing your Requisition Form. Place the biohazard bag and your completed test requisition form into the shipping box.
Samples must be shipped within 24 hours of collection. Ship your samples via UPS. To prepare your samples for shipping:
Results should be released to your provider 7 business days after samples are received at the lab. Rupa Health cannot guarantee processing time.
Article: SIBO Testing 101: A Complete Guide to The Top 3 SIBO Tests
Article: How to Use the trio-smart Test from Gemelli Biotech in Clinic
[1.] Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther. 2007 Feb 15;25(4):349-63. doi: 10.1111/j.1365-2036.2006.03186.x. Epub 2007 Jan 8. PMID: 17217453.
[2.] Kim Y, Choi CH. Role of Fructose Malabsorption in Patients With Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018 Apr 30;24(2):161-163. doi: 10.5056/jnm18057. PMID: 29605972; PMCID: PMC5885715.
[3.] Ledochowski M, Widner B, Bair H, Probst T, Fuchs D. Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol. 2000 Oct;35(10):1048-52. doi: 10.1080/003655200451162. PMID: 11099057.
[4.] Losurdo G, Leandro G, Ierardi E, Perri F, Barone M, Principi M, Leo AD. Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis. J Neurogastroenterol Motil. 2020 Jan 30;26(1):16-28. doi: 10.5056/jnm19113. PMID: 31743632; PMCID: PMC6955189.
[5.] Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, Biesiekierski JR, Smith S, Gibson PR, Muir JG. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010 Aug;25(8):1366-73. doi: 10.1111/j.1440-1746.2010.06370.x. PMID: 20659225.
[6.] Pimentel, Mark MD, FRCP(C), FACG1; Saad, Richard J. MD, FACG2; Long, Millie D. MD, MPH, FACG (GRADE Methodologist)3; Rao, Satish S. C. MD, PhD, FRCP, FACG4. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. The American Journal of Gastroenterology 115(2):p 165-178, February 2020. | DOI: 10.14309/ajg.0000000000000501
[7.] Rana SV, Malik A. Hydrogen breath tests in gastrointestinal diseases. Indian J Clin Biochem. 2014 Oct;29(4):398-405. doi: 10.1007/s12291-014-0426-4. Epub 2014 Mar 21. PMID: 25298621; PMCID: PMC4175689.
[8.] Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, Schmulson M, Valdovinos M, Zakko S, Pimentel M. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017 May;112(5):775-784. doi: 10.1038/ajg.2017.46. Epub 2017 Mar 21. PMID: 28323273; PMCID: PMC5418558.
[9.] Tahli Singer-Englar, Rezaie A, Gupta K, et al. 182 - Competitive Hydrogen Gas Utilization by Methane- and Hydrogen Sulfide-Producing Microorganisms and Associated Symptoms: Results of a Novel 4-Gas Breath Test Machine. Gastroenterology. 2018;154(6):S-47. doi:https://doi.org/10.1016/s0016-5085(18)30625-5
The trio-smart Fructose Malabsorption Test measures the level of hydrogen in patients' breath to aid in the identification of fructose malabsorption.